Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides
暂无分享,去创建一个
[1] L. Lewis,et al. Ultrastructural changes associated with reduced mitochondrial DNA and impaired mitochondrial function in the presence of 2'3'-dideoxycytidine , 1992, Antimicrobial Agents and Chemotherapy.
[2] R. N. Brogden,et al. Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection. , 1992, Drugs.
[3] C. H. Chen,et al. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. , 1991, Molecular pharmacology.
[4] M. Dalakas,et al. Mitochondrial myopathy caused by long-term zidovudine therapy. , 1990, The New England journal of medicine.
[5] M. Dalakas,et al. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2′,3′‐dideoxycytidine (ddc) , 1989, Muscle & nerve.
[6] H. Mitsuya,et al. In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine. , 1989, Science.
[7] C. H. Chen,et al. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine. , 1989, The Journal of biological chemistry.
[8] H. Mitsuya,et al. PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT) , 1988, The Lancet.
[9] J. Meldolesi,et al. Subcellular redistribution of lysosomal enzymes during caerulein-induced pancreatitis. , 1987, The American journal of physiology.
[10] M A Fischl,et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.
[11] N. Bresolin,et al. Peripheral neuropathy in mitochondrial disease , 1987, Journal of the Neurological Sciences.
[12] H. Mitsuya,et al. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[13] B. Haynes,et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. , 1984, Science.
[14] J. Chermann,et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.
[15] M. Steer,et al. Effects of ethionine on digestive enzyme synthesis and discharge by mouse pancreas. , 1980, The American journal of physiology.
[16] G. Godman,et al. RESPIRATORY ENZYMES AND MITOCHONDRIAL MORPHOLOGY OF HELA AND L CELLS TREATED WITH CHLORAMPHENICOL AND ETHIDIUM BROMIDE , 1972, The Journal of cell biology.
[17] S. Steinberg,et al. 2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. , 1993, The Journal of infectious diseases.
[18] S. Mellgren,et al. Early mitochondrial changes in chronic progressive ocular myopathy. , 1990, European neurology.
[19] F. N. Ghadially,et al. Chloramphenicol-induced mitochondrial and ultrastructural changes in hemopoietic cells. , 1976, Archives of pathology & laboratory medicine.